Abstract
Cardiac arrhythmias are common in acute intoxication, although epidemiological data are often restricted to specific substances. A 10 % incidence of cardiac arrhythmias during acute intoxication has been reported by a referral poison center in Germany that analyzed the data of 91,285 patients referred between 1995 and 2003 using the inquiries of physicians and paramedics [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Von Mach AA, Brinkmann X, Weilemann LS. Epidemiology of cardiac dysrhythmias in acute intoxication. Z Kardiol. 2004;93 Suppl 4:IV9–15.
European drug report 2014: trends and developments. http://www.emcdda.europa.eu.
Kesha K, Boggs CL, Ripple MG. Methylenedioxypyrovalerone (bath salts) related death: case report and review of the literature. J Forensic Sci. 2013;58(6):1654–9.
WADA list 2015, yearly updated www.wada-ama.org.
Tokish JM, Kocher MS, Hawkins RJ. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med. 2004;32:1543–53.
Dhar R, Stout W, Link SM, Homoud MK, Weinstock J, Estes III M. Cardiovascular toxicities of performance-enhancing substances in sports. Mayo Clin Proc. 2005;80:1307–15.
Kutscher EC, Lund BC, Perry PJ. Anabolic steroids: a review for the clinician. Sports Med. 2002;32:285–96.
Gauthier J. The heart and doping. Arch Mal Coeur Vaiss. 2006;99:1126–9.
Calfee R, Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics. 2006;117:577–89.
Bouchard R, Weber AR, Geiger JD. Informed decision-making on sympathomimetic use in sport and health. Clin J Sport Med. 2002;12:209–24.
Gray SD, Fatovich DM, McCoubrie DL, Daly FF. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust. 2007;186:336–9.
Krome CN, Tucker AM. Cardiac arrhythmia in a professional football player. Was ephedrine to blame? Phys Sports Med. 2003;31:1–12.
Gee P, Richardson S, Woltersdorf W, Moore G. Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand. NZ Med J. 2005;18:1227–37.
Hall AP, Henry JA. Acute toxic effects of “Ecstasy” (MDMA and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. 2006;96:678–85.
Ricaurte GA, McCann UD. Recognition and management of complications of new recreational drug use. Lancet. 2005;365:2137–45.
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833–8.
Zahn KA, Li RL, Purssell RA. Cardiovascular toxicity after ingestion of ‘herbal ecstasy’. J Emerg Med. 1999;17:289–91.
Furlanello F, Vitali Serdoz L, Cappato R, De Ambroggi L. Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil. 2007;14:487–94.
Hunterdon Drug Awareness Program (HDAP). Comprehensive drug information on “bath salts” (MDPV, Mephedrone). Flemington: HDAP. Updated 29 June 2012; http://www.hdap.org/mdpv.html.
Benzie F, Hekman K, Cameron L, Wade DR, Miller C, Smolinske S, et al. Emergency department visits after use of a drug sold as “bath salts”–Michigan, November 13, 2010-March 31, 2011. MMWR Morb Mortal Wkly Rep. 2011;19:624–47.
Billman GE. Cocaine: a review of its toxic actions on cardiac function. Crit Rev Toxicol. 1995;25:113–32.
Karch SB. Cocaine cardiovascular toxicity. South Med J. 2005;98:794–9.
Kloner RA, Hale S, Alker K, Rezkalla S. The effects of acute and chronic cocaine use on the heart. Circulation. 1992;85:407–19.
Hale SL, Lehmann MH, Kloner RA. Electrocardiographic abnormalities after acute administration of cocaine in the rat. Am J Cardiol. 1989;63:1529–30.
Taylor D, Paroish D, Thompson K, Cavaliere M. Cocaine induced prolongation of the QT interval. Emerg Med J. 2004;21:252–3.
Magnano AR, Talathoti NB, Hallur R, Jurus DT, Dizon J, Holleran S, et al. Effect of Acute Cocaine Administration on the QTc Interval of Habitual Users. Am J Cardiol. 2006;97:1244–6.
Fuller TE, Milling TJ, Price B, Spangle K. Therapeutic hypothermia in cocaine-induced cardiac arrest. Ann Emerg Med. 2008;51:135–7.
Hollander JE, Hoffman RS. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med. 1992;10:169–77.
Turhan H, Aksoy Y, Ozgun Tekin G, Yetkin E. Cocaine-induced acute myocardial infarction in young individuals with otherwise normal coronary risk profile: is coronary microvascular dysfunction one of the underlying mechanisms? Int J Cardiol. 2007;114:106–7.
Mittleman MA, Mintzer D, Maclure M, Togler GH, Sherwood JB, Muller JE. Triggering of myocardial infarction by cocaine. Circulation. 1999;99:2737–41.
Guo J, Gang H, Zhang S. Molecular determinants of cocaine block of human ether-a-go-go-related gene potassium channels. J Pharmacol Exp Ther. 2006;317:865–74.
Parker RB, Perry GY, Horan LG, Flowers NC. Comparative effects of sodium bicarbonate and sodium chloride on reversing cocaine-induced changes in the electrocardiogram. J Cardiovasc Pharmacol. 1999;34:864–9.
Littmann L, Monroe MH, Svenson RH. Brugada-type electrocardiographic pattern induced by cocaine. Mayo Clin Proc. 2000;75:845–9.
Randall T. Cocaine, alcohol mix in body to form even longer lasting, more lethal drug. JAMA. 1992;267:1043–4.
Lindsay AC, Foale RA, Warren O, Henry JA. Cannabis as a precipitant of cardiovascular emergencies. Int J Cardiol. 2005;104:230–2.
Fisher BA, Ghuran A, Vadamalai V, Antonios TF. Cardiovascular complications induced by cannabis smoking: a case report and review of the literature. Emerg Med J. 2005;22:679–80.
Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol. 2007;118:141–4.
Pita-Fernandez S, Lombardia-Cortina M, Orozco-Veltran D, Gil-Guillen V. Clinical manifestations of elderly patients with digitalis intoxication in the emergency department. Arch Geron Geriat. 2011;53:e106–10.
Davis JA, Ravishanktar C, Shah MJ. Multiple cardiac arrhythmias in a previously healthy child: a case of accidental digitalis intoxication. Pediatr Emerg Care. 2006;22(6):430–4.
Goranitou G, Stavrianaki D, Babalis D. Wide QRS tachycardia caused by severe hyperkalaemia and digoxin intoxication. Acta Cardiol. 2005;60(4):437–41.
Deret RW, Horowitz BZ. Cardiotoxic drugs. Emerg Med Clin North Am. 1995;13:771–91.
Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. N Engl J Med. 1993;328(19):1398–405.
Mann JJ. The medical management of depression. N Engl J Med. 2005;353(17):1819–34.
Shader RI, Greenblatt DJ. Selective serotonin reuptake inhibitor antidepressants: cardiovascular complications-sorting through findings. J Clin Psychopharmacol. 2001;21(5):467–8.
Warrington SJ, Padgham C, Lader M. The cardiovascular effects of antidepressants. Psychol Med Monogr Suppl. 1989;16:i–iii, 1–40.
Yamada M, Yasuhara H. Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology. 2004;25(1–2):215–21. Review.
Goldman LS, Alexander RC, Luchins DJ. Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects. J Clin Psychiatry. 1986;47(5):225–9.
Murray JB. Cardiac disorders and antidepressant medications. J Psychol. 2000;134(2):162–8. Review.
Periti P, Mazzei T, Mini E, Novelli A. Adverse effects of macrolide antibacterials. Drug Saf. 1993;9(5):346–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Vitali-Serdoz, L., Furlanello, F., Puggia, I. (2016). Cardiac Arrhythmias in Drug Abuse and Intoxication. In: Zecchin, M., Sinagra, G. (eds) The Arrhythmic Patient in the Emergency Department. Springer, Cham. https://doi.org/10.1007/978-3-319-24328-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-24328-3_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24326-9
Online ISBN: 978-3-319-24328-3
eBook Packages: MedicineMedicine (R0)